Browsing Tag
Supernus Pharmaceuticals
2 posts
Supernus Pharmaceuticals and Indivior target $125m in savings through CNS merger
Supernus Pharmaceuticals and Indivior plan a $2.2 billion CNS merger with 11 medicines, $125 million in synergies and a fourth-quarter close.
Supernus wins FDA approval for ONAPGO, a continuous infusion therapy for Parkinson’s disease
The U.S. Food and Drug Administration (FDA) has granted approval to Supernus Pharmaceuticals, Inc. for ONAPGO (apomorphine hydrochloride)…